UncategorizedAlchemab launches Phase 1 trial for ATLX-1282, secures extra $32M funding – Longevity.Technology Empower Meds / September 11, 2025
UncategorizedAnavex reports blarcamesine yields near-normal aging cognition in Alzheimer’s trial – Longevity.Technology Empower Meds / September 11, 2025
UncategorizedAviv Clinics reports HBOT improves long-term post-concussion cognitive function – Longevity.Technology Empower Meds / September 11, 2025
UncategorizedCellvie lands funding to advance therapeutic mitochondria transplantation Empower Meds / September 10, 2025
UncategorizedPonce becomes SENOTHERAPEUTIX, flexing into hub and spoke model Empower Meds / September 10, 2025
UncategorizedOmada Health analysis finds durable weight maintenance after GLP-1 use – Longevity.Technology Empower Meds / September 10, 2025
UncategorizedOversubscribed £50M Series B funds NRG Therapeutics’ clinical push – Longevity.Technology Empower Meds / September 10, 2025
